Akebia Therapeutics Competitors, Revenue and Alternatives
Navigation
Overview
Industry Ranking
Growjo 10k Ranking
Estimated Revenue & Financials
- Akebia Therapeutics's estimated annual revenue is currently $235M per year.
- Akebia Therapeutics received $85.0M in venture funding in March 2018.
- Akebia Therapeutics's estimated revenue per employee is $560,859
- Akebia Therapeutics's total funding is $142.1M.
Employee Data
- Akebia Therapeutics has 419 Employees.
- Akebia Therapeutics grew their employee count by 14% last year.
- Akebia Therapeutics currently has 12 job openings.
Akebia Therapeutics Competitors
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
| $8.7M | 56 | -12% | N/A | |
| $8.7M | 56 | 60% | N/A | |
| $16.4M | 106 | 14% | N/A | |
| $89.4M | 577 | N/A | N/A | |
| N/A | 220 | N/A | N/A | |
| $15.3M | 99 | -17% | N/A | |
| N/A | 94 | N/A | N/A | |
| $17.2M | 111 | 9% | N/A | |
| $74.9M | 1277 | 31% | N/A | |
| N/A | 47 | N/A | N/A |
What Is Akebia Therapeutics?
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for patients with chronic kidney disease. For more information, please visit our website at www.akebia.com.
keywords:Biotechnology,Healthcare,Pharmaceuticals419
Number of Employees
$235M
Revenue (est)
12
Current Jobs
14%
Employee Growth %
$142.1M
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Executive Contacts
| Name | Title | |
|---|---|---|
| Mark Rosch | Senior VP, Regulatory Affairs, Quality Assurance & CMC | |
| Steven Burke | Chief Medical Officer | |
| Lee Kaukas | Senior Director, Alliance Management | |
| John Butler | President And Ceo | |
| Jason Amello | Senior Vice President, Chief Financial Officer and Treasurer | Email Available |
| Randy Bennett | Director & Chief Of Staff, Cmo Office | |
| Susan Brady | Corporate Communications Manager | Email Available |
| Ute Miner | Project Manager | |
| Xiao Hu | Director | |
| Young Chun Jung | Director | Email Available |
Akebia Therapeutics News
CAMBRIDGE, Mass.--(BUSINESS WIRE)--. Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on the development and ...
On Tuesday, shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) marked $4.11 per share versus a previous $4.13 closing price. With having ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is among the top losers of the stock market today, sinking -3.89% or (-0.16 points) to $3.95 from its ...
Akebia Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2008-12-22 | $15.1M | A | Article | |
| 2009-07-29 | $16.0M | Undisclosed | Novartis Bioventures Ltd, Venture Investors LLC | Article |
| 2011-04-27 | $22.0M | Undisclosed | Novartis Venture Fund, Venture Investors LLC | Article |
| 2012-01-10 | $4.1M | Series B | Novartis Bioventures, Venture Investors | Article |
| 2013-06-05 | $41.0M | C | Satter Investment Management L | Article |
| 2015-04-24 | $64.6M | Undisclosed | UBS Investment Bank | Article |
| 2017-07-07 | $67.0M | Undisclosed | Morgan Stanley | Article |
| 2018-03-26 | $85.0M | Undisclosed | Morgan Stanley | Article |
Akebia Therapeutics Executive Hires
| Date | Name | Title | Reference |
|---|---|---|---|
| 2013-08-29 | John P. Butler | President/CEO | Article |
| 2013-10-17 | Jason A Amello | SVP/CFO/Treasurer | Article |
| 2014-01-14 | Nicole R. Hadas | VP General Counsel | Article |
| 2014-08-07 | Brad Maroni | SVP/Chief Medical Officer | Article |
| 2015-09-11 | Teresa Compton | SVP/CSO | Article |
| 2017-05-29 | Rita Jain | Chief Medical Officer | Article |
Akebia Therapeutics Acquisitions
| Date | Company Name | Amount | Notes | Reference |
|---|---|---|---|---|
| 2018-06-29 | Keryx Biopharmaceuticals, Inc | Article |